Karolinska Development AB (publ) KDEV.ST Open Karolinska Development AB (publ) in new tab
Karolinska Development AB (publ) Analysis (KDEV.ST)
Is Karolinska Development AB (publ) a good investment? Karolinska Development AB (publ) (KDEV.ST) is currently trading at 0.3000 SEK.
Earnings Schedule: Karolinska Development AB (publ) is expected to release its next earnings report on April 28, 2026. The market consensus estimate for Forward EPS is -0.10.
Investor FAQ
Does Karolinska Development AB (publ) pay a dividend?
No, it does not currently pay a dividend.
What asset class is Karolinska Development AB (publ)?
Karolinska Development AB (publ) is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be April 28, 2026. The company currently has a trailing EPS of -0.41.
Company Profile
KDventures AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. The company was formerly known as Karolinska Development AB (publ) and change its name to KDventures AB in February 2026. KDventures AB was founded in 2003 and is headquartered in Solna, Sweden.
Dividends
Historical Split Corporate Actions
| Split Date | Split Ratio to 1 |
|---|---|
| Jan. 13, 2022 | 1.130000 |
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion